Muscle Stimulation Devices Market, by Product Type (Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Current Electrical Stimulation (IFC), Burst Mode Alternating Current (BMAC), Neuromuscular Electrical Stimulation (NMES)), By Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management), By End user (Hospitals, Physiotherapy Clinics, Sports Clinics, Home Care), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Muscle stimulation devices encompasses Stimulating muscles repeatedly with electricity may eventually result in muscles that are strengthened and toned to some extent but will not, based on currently available data, create a major change in your appearance without the addition of diet and regular exercise electrical muscle stimulators for patients who require muscle re-education, relaxation of muscle spasms, increased range of motion, prevention of muscle atrophy, and for treating other medical conditions, which usually result from a stroke, a serious injury, or major surgery. Again, the effect of using these devices is primarily to help a patient recover from impaired muscle function due to a medical condition, not to increase muscle size enough to affect appearance. The high prevalence of spinal cord disorder and increasing application of spinal cord injury susceptibilities associated with pain management is expected to boost the global muscle stimulation devices market growth.
Market Dynamics
The key market players are focusing on adoption of growth strategies such as product launches, which is attributed to the growth of global muscle stimulation devices market. For instance, in November 2022, MyndTec Inc., an emerging leader in neurological rehabilitation, announced the launch of its newest product, MyndStepTM, to its functional electrical stimulation (FES) portfolio. MyndStep is intended to provide ankle dorsiflexion in individuals who have a dropped foot as a consequence of an upper motor neuron injury. For instance,in January 2020, Omron Healthcare, Inc. is manufactures and distributes personal wellness products introduced nerve stimulator (model HV-F013), to provide drug-free pain relief. Further, owing to its suitability for treating nearly all types of pain, including nerve, muscle, and joint pain, patients will feel better and need opioids less frequently.
Key features of the study:
This report provides an in-depth analysis of the global muscle stimulation devices market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global muscle stimulation devices market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc.,Omron Corporation Medtronic plc., Abbott., Boston Scientific Corporation., BTL Corporate., Nevro Corp., Cogentix Medical and BioMedical Life Systems
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global muscle stimulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global muscle stimulation devices market
Detailed Segmentation:
Muscle Stimulation Devices Market, By Product Type:
Transcutaneous Electrical Nerve Stimulation (TENS)
Interferential Current Electrical Stimulation (IFC)
Burst Mode Alternating Current (BMAC)
Neuromuscular Electrical Stimulation (NMES)
Muscle Stimulation Devices Market, By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Muscle Stimulation Devices Market, By End User:
Hospitals
Physiotherapy Clinics
Sports Clinics
Home Care
Muscle Stimulation Devices Market, By Region:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country:
GCC
Israel
Rest of Middle East
Africa
By Country:
South Africa
Central Africa
North Africa
Company Profiles
DJO Global Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Zynex Inc.
Neurometrix Inc
R.S. Medical Inc
Omron Corporatio
Abbott
Boston Scientific Corporation
BTL Corporate
Nevro Corp
Cogentix Medical
BioMedical Life System
“*” marked represents similar segmentation in other categories in the respective section.